image
Healthcare - Medical - Care Facilities - NYSE - US
$ 98.85
-2.33 %
$ 9.96 B
Market Cap
23.59
P/E
1. INTRINSIC VALUE

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others.[ Read More ]

The intrinsic value of one EHC stock under the base case scenario is HIDDEN Compared to the current market price of 98.8 USD, Encompass Health Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart EHC

image
FINANCIALS
4.8 B REVENUE
10.41%
732 M OPERATING INCOME
16.55%
362 M NET INCOME
-1.18%
851 M OPERATING CASH FLOW
20.54%
-603 M INVESTING CASH FLOW
3.86%
-197 M FINANCING CASH FLOW
-35.35%
1.35 B REVENUE
3.83%
209 M OPERATING INCOME
-3.01%
148 M NET INCOME
29.08%
-460 M OPERATING CASH FLOW
-211.55%
-195 M INVESTING CASH FLOW
-35.75%
-196 M FINANCING CASH FLOW
-203.72%
Balance Sheet Decomposition Encompass Health Corporation
image
Current Assets 842 M
Cash & Short-Term Investments 69.1 M
Receivables 612 M
Other Current Assets 161 M
Non-Current Assets 5.26 B
Long-Term Investments 110 M
PP&E 3.51 B
Other Non-Current Assets 1.64 B
Current Liabilities 656 M
Accounts Payable 170 M
Short-Term Debt 48.9 M
Other Current Liabilities 438 M
Non-Current Liabilities 3.15 B
Long-Term Debt 2.91 B
Other Non-Current Liabilities 237 M
EFFICIENCY
Earnings Waterfall Encompass Health Corporation
image
Revenue 4.8 B
Cost Of Revenue 3.87 B
Gross Profit 934 M
Operating Expenses 694 M
Operating Income 732 M
Other Expenses 370 M
Net Income 362 M
RATIOS
19.44% GROSS MARGIN
19.44%
15.24% OPERATING MARGIN
15.24%
7.33% NET MARGIN
7.33%
21.37% ROE
21.37%
5.77% ROA
5.77%
14.16% ROIC
14.16%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Encompass Health Corporation
image
Net Income 362 M
Depreciation & Amortization 274 M
Capital Expenditures -583 M
Stock-Based Compensation 50.6 M
Change in Working Capital 50.3 M
Others 171 M
Free Cash Flow 268 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Encompass Health Corporation
image
Wall Street analysts predict an average 1-year price target for EHC of $101 , with forecasts ranging from a low of $95 to a high of $110 .
EHC Lowest Price Target Wall Street Target
95 USD -3.89%
EHC Average Price Target Wall Street Target
101 USD 2.38%
EHC Highest Price Target Wall Street Target
110 USD 11.28%
4. DIVIDEND ANALYSIS
0.16% DIVIDEND YIELD
0.17 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Encompass Health Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
1.91 M USD 2
6-9 MONTHS
4.97 M USD 2
9-12 MONTHS
711 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
167 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
3 months ago
Aug 13, 2024
Sell 1.05 M USD
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
- 12162
86.33 USD
3 months ago
Aug 13, 2024
Sell 8.53 K USD
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
- 98
87.03 USD
5 months ago
May 24, 2024
Sell 850 K USD
Charbonneau Elissa Joy
Chief Medical Officer
- 10000
85.02 USD
6 months ago
May 06, 2024
Sell 1.22 M USD
Darby John Patrick
EVP, Gen Counsel & Secretary
- 14543
83.94 USD
6 months ago
May 03, 2024
Bought 167 K USD
CARMICHAEL GREG D
Director
+ 2000
83.73 USD
6 months ago
Apr 30, 2024
Sell 3.75 M USD
Tarr Mark J
President & CEO
- 44976
83.27 USD
1 year ago
Nov 13, 2023
Sell 711 K USD
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
- 11215
63.39 USD
1 year ago
Aug 17, 2023
Sell 577 K USD
Charbonneau Elissa Joy
Chief Medical Officer
- 8294
69.58 USD
1 year ago
Aug 16, 2023
Sell 1.8 M USD
Tarr Mark J
President & CEO
- 25330
71.06 USD
1 year ago
Feb 10, 2023
Sell 1.09 M USD
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
- 17895
60.78 USD
2 years ago
Oct 31, 2022
Bought 100 K USD
CARMICHAEL GREG D
Director
+ 1830
54.67 USD
2 years ago
Aug 17, 2022
Sell 1.09 M USD
Tarr Mark J
President & CEO
- 20449
53.25 USD
2 years ago
May 05, 2022
Bought 66.5 K USD
O'Connor Kevin J.
director:
+ 1000
66.48 USD
2 years ago
Dec 02, 2021
Bought 20 K USD
Williams Terrance
Director
+ 354
56.61 USD
3 years ago
Mar 08, 2021
Sell 699 K USD
Price Andrew L
Chief Accounting Officer
- 8589
81.4 USD
4 years ago
Nov 17, 2020
Sell 500 K USD
Charbonneau Elissa Joy
Chief Medical Officer
- 6650
75.22 USD
4 years ago
May 28, 2020
Sell 1.74 M USD
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
- 23011
75.73 USD
4 years ago
May 28, 2020
Sell 37.3 K USD
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
- 490
76.15 USD
4 years ago
May 15, 2020
Sell 162 K USD
Jacobsmeyer Barbara Ann
President, Inpatient Hospitals
- 2500
64.73 USD
4 years ago
May 14, 2020
Sell 1.62 M USD
Tarr Mark J
President & CEO
- 26132
61.92 USD
4 years ago
Mar 12, 2020
Sell 118 K USD
CORRELL DONALD L
Director
- 2000
59.04 USD
4 years ago
Mar 12, 2020
Bought 491 K USD
Anthony April Kaye Bullock
CEO & President, Home Health
+ 8083
60.76 USD
4 years ago
Mar 12, 2020
Bought 1.23 M USD
Anthony April Kaye Bullock
CEO & President, Home Health
+ 20580
59.95 USD
4 years ago
Mar 12, 2020
Bought 2.45 M USD
Anthony April Kaye Bullock
CEO & President, Home Health
+ 41607
58.91 USD
4 years ago
Mar 12, 2020
Bought 2.26 M USD
Anthony April Kaye Bullock
CEO & President, Home Health
+ 38882
58.09 USD
4 years ago
Mar 12, 2020
Bought 615 K USD
Anthony April Kaye Bullock
CEO & President, Home Health
+ 10738
57.29 USD
4 years ago
Mar 12, 2020
Bought 249 K USD
Anthony April Kaye Bullock
CEO & President, Home Health
+ 4410
56.44 USD
4 years ago
Mar 12, 2020
Bought 38.2 K USD
Anthony April Kaye Bullock
CEO & President, Home Health
+ 700
54.5 USD
4 years ago
Mar 11, 2020
Bought 64.1 K USD
HIGDON LEO I JR
Director
+ 1000
64.07 USD
4 years ago
Mar 11, 2020
Bought 2.57 M USD
Anthony April Kaye Bullock
CEO & President, Home Health
+ 40000
64.24 USD
7. News
Encompass Health Rehabilitation Hospital of Houston at The Medical Center Now Open in Texas The 61-bed inpatient rehabilitation hospital is Encompass Health's first hospital fully constructed using prefabricated modules. BIRMINGHAM, Ala. prnewswire.com - 5 days ago
Should Value Investors Buy Encompass Health (EHC) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 5 days ago
EHC or ASTH: Which Is the Better Value Stock Right Now? Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Encompass Health (EHC) and Astrana Health, Inc. (ASTH). But which of these two stocks presents investors with the better value opportunity right now? zacks.com - 1 week ago
Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run? Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. zacks.com - 1 week ago
Encompass Health (EHC) is a Top-Ranked Value Stock: Should You Buy? The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com - 1 week ago
Encompass Health Q3 Earnings Beat on Higher Discharges, Stock Up 6.3% EHC's third-quarter results benefit from improved patient discharges. Higher operating expenses act as a partial offset. zacks.com - 1 week ago
Encompass Health Corporation (EHC) Q3 2024 Earnings Call Transcript Encompass Health Corporation (NYSE:EHC ) Q3 2024 Earnings Conference Call October 29, 2024 10:00 AM ET Company Participants Mark Miller - Chief Investor Relations Officer Mark Tarr - President and Chief Executive Officer Douglas Coltharp - Executive Vice President and Chief Financial Officer Conference Call Participants Christian Porter - Bank of America Securities Andrew Mok - Barclays Michael Murray - RBC Capital Markets Meghan Holtz - Jefferies Kieran Ryan - Deutsche Bank Scott Fidel - Stephens Jared Haase - William Blair Zach Haggerty - KeyBanc Capital Markets Operator Good morning, everyone, and welcome to Encompass Health's Third Quarter 2024 Earnings Conference Call. At this time, I would like to inform all participants that their lines will be in a listen-only mode. seekingalpha.com - 2 weeks ago
Compared to Estimates, Encompass Health (EHC) Q3 Earnings: A Look at Key Metrics While the top- and bottom-line numbers for Encompass Health (EHC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com - 2 weeks ago
Encompass Health (EHC) Tops Q3 Earnings and Revenue Estimates Encompass Health (EHC) came out with quarterly earnings of $1.03 per share, beating the Zacks Consensus Estimate of $0.94 per share. This compares to earnings of $0.86 per share a year ago. zacks.com - 2 weeks ago
Encompass Health reports results for third quarter 2024 Increases full-year guidance BIRMINGHAM, Ala. , Oct. 28, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the third quarter ended September 30, 2024. prnewswire.com - 2 weeks ago
Are Investors Undervaluing Encompass Health (EHC) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 3 weeks ago
8. Profile Summary

Encompass Health Corporation EHC

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 9.96 B
Dividend Yield 0.16%
Description Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
Contact 9001 Liberty Parkway, Birmingham, AL, 35242 https://www.encompasshealth.com
IPO Date Sept. 24, 1986
Employees 27481
Officers Mr. Mark Miller Senior Vice President of Investor Relations & Strategic Planning Mr. Rusty Yeager Chief Information Officer & Senior Vice President Mr. Andrew L. Price Senior Vice President & Chief Accounting Officer Dr. Elissa Joy Charbonneau D.O., M.S. Chief Medical Officer Mr. Mark J. Tarr Chief Executive Officer, President & Director Mr. Frank Brown President of Southwest Region Mr. Anthony A. Hernandez Chief Human Resources Officer Mr. John Patrick Darby Executive Vice President, General Counsel & Corporate Secretary Ms. Dawn Rock Chief Compliance Officer Mr. Douglas E. Coltharp Executive Vice President & Chief Financial Officer